{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:33:08Z","timestamp":1765546388848,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,25]],"date-time":"2020-01-25T00:00:00Z","timestamp":1579910400000},"content-version":"am","delay-in-days":358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Pathologie"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.annpat.2018.08.005","type":"journal-article","created":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T10:09:19Z","timestamp":1544695759000},"page":"18-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["N\u00e9phropathie cristalline secondaire au m\u00e9thotrexate\u00a0: une entit\u00e9 rarement objectiv\u00e9e sur biopsie r\u00e9nale"],"prefix":"10.1016","volume":"39","author":[{"given":"Prudence","family":"Colpart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"F\u00e9lix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl.\u00a01","key":"10.1016\/j.annpat.2018.08.005_bib0045","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/j.nephro.2018.02.015","article-title":"Renal toxicity of high-dose methotrexate","volume":"14","author":"Garcia","year":"2018","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.annpat.2018.08.005_bib0050","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1097\/CCM.0b013e318168e375","article-title":"An overview of drug-induced acute kidney injury","volume":"36","author":"Pannu","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.annpat.2018.08.005_bib0055","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1053\/j.ajkd.2016.11.004","article-title":"AJKD Atlas of renal pathology: indinavir nephrotoxicity","volume":"69","author":"Fogo","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.annpat.2018.08.005_bib0060","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/j.ajkd.2013.06.023","article-title":"Triamterene crystalline nephropathy","volume":"63","author":"Nasr","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.annpat.2018.08.005_bib0065","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1634\/theoncologist.11-6-694","article-title":"Understanding and managing methotrexate nephrotoxicity","author":"Wideman","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.annpat.2018.08.005_bib0070","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/ki.2014.317","article-title":"A case of crystalline nephropathy","volume":"87","author":"Pazhayattil","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.annpat.2018.08.005_bib0075","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1056\/NEJMc1507547","article-title":"Acute methotrexate-induced crystal nephropathy","volume":"373","author":"Garneau","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annpat.2018.08.005_bib0040","doi-asserted-by":"crossref","first-page":"713","DOI":"10.5858\/arpa.2011-0565-RA","article-title":"Crystalline nephropathies","volume":"136","author":"Herlitz","year":"2012","journal-title":"Arch Pathol Lab Med"}],"container-title":["Annales de Pathologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649818301354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649818301354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:33:59Z","timestamp":1759332839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0242649818301354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0242649818301354"],"URL":"https:\/\/doi.org\/10.1016\/j.annpat.2018.08.005","relation":{},"ISSN":["0242-6498"],"issn-type":[{"type":"print","value":"0242-6498"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N\u00e9phropathie cristalline secondaire au m\u00e9thotrexate\u00a0: une entit\u00e9 rarement objectiv\u00e9e sur biopsie r\u00e9nale","name":"articletitle","label":"Article Title"},{"value":"Annales de Pathologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annpat.2018.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}